Lenvatinib and Tylenol drug interactions for men aged 60+ (a phase IV clinical study of FDA data)

Summary:

Drug interactions are found for men aged 60+ who take Lenvatinib (lenvatinib) and Tylenol (acetaminophen) together. We list drug interactions by the duration when the drugs are taken. This phase IV study is created by eHealthMe based on reports of 22 people from the FDA, and is updated regularly.



On Jun, 17, 2026

22 men aged 60+ who take Lenvatinib, Tylenol and have drug interactions are studied.


What is Lenvatinib?

Lenvatinib has active ingredients of lenvatinib. eHealthMe is studying from 3,586 Lenvatinib users. Check the latest studies of Lenvatinib.

What is Tylenol?

Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,308 Tylenol users. Check the latest studies of Tylenol.

Number of reports submitted per year:

Lenvatinib and Tylenol drug interactions in men aged 60+.

Most common drug interactions over time *:

< 1 month:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Autoimmune hepatitis
  3. Dehydration (dryness resulting from the removal of water)
  4. Hypotension (abnormally low blood pressure)
  5. Rectal haemorrhage (bleeding from anus)
  6. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  7. Decreased appetite
  8. Acute respiratory failure
  9. Blood bilirubin increased
  10. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)

1 - 6 months:

  1. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  2. Rectal haemorrhage (bleeding from anus)

6 - 12 months:

  1. Colonic fistula (abnormal passage to other organ from colon)

1 - 2 years:

  1. Hypotension (abnormally low blood pressure)
  2. Pneumonia

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Colonic fistula (abnormal passage to other organ from colon)
  2. Acute respiratory failure
  3. Blood bilirubin increased
  4. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  5. Lymphocyte count decreased
  6. Hypotension (abnormally low blood pressure)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Decreased appetite
  9. Dehydration (dryness resulting from the removal of water)
  10. Overdose

* Approximation only. Some reports may have incomplete information.

Do you take Lenvatinib and Tylenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, lenvatinib and acetaminophen (the active ingredients of Lenvatinib and Tylenol, respectively), and Lenvatinib and Tylenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: